A comprehensive pan-cancer multi-omics analysis identifies CDKN2A as a promising biomarker associated with clinical outcomes and immune infiltration

Yi Shi, Dong Zhan, Xin Sun
Cytokine · Elsevier · DOI: 10.1016/j.cyto.2026.157228

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles